Aminoglycoside dosing in the critical care patient: a case report of tertiary pharmaceutical care.
OBJECTIVE
To describe special dosage considerations for aminoglycoside antibiotics in critically ill patients from a pharmaceutical care perspective.


METHODS
Case report and discussion.


METHODS
A nontertiary care regional medical center.


METHODS
A 21-year-old male college student involved in a moving vehicle accident who sustained a closed head injury and collapsed right lung with subsequent development of nosocomial pneumonia.


METHODS
Resolution of pneumonia and discharge from hospital.


METHODS
Tertiary level pharmaceutical care.


RESULTS
Pneumonia resolved and patient was transferred to rehabilitation center.


CONCLUSIONS
Tertiary pharmaceutical care provided by the pharmacist includes appropriate choice and monitoring of pharmacotherapy and pharmacokinetic drug dosing to promote good patient outcome.
Wade
W E
WE
College of Pharmacy, University of Georgia, Athens.
McCall
C Y
CY
Tyson
D W
DW
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003422:Critical Care; D003428:Cross Infection / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007902:Length of Stay; D008297:Male; D008991:Monitoring, Physiologic; D011552:Pseudomonas Infections / Q000097:blood / Q000188:drug therapy*; D014031:Tobramycin / Q000008:administration & dosage / Q000097:blood
D000900:Anti-Bacterial Agents; D014031:Tobramycin